GFAP antibody (AA 411-422)
Quick Overview for GFAP antibody (AA 411-422) (ABIN6656791)
Target
See all GFAP AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 411-422
-
Supplier Product No.
- 200-301-w55
-
Supplier
- Rockland
-
Purpose
- GFAP Antibody
-
Cross-Reactivity (Details)
- A BLAST analysis was used to suggest cross-reactivity with rat and mouse based on 100 % homology with the immunizing sequence.
-
Purification
- Anti-GFAP Antibody was purified from concentrated tissue culture supernate by Protein G chromatography.
-
Sterility
- Sterile filtered
-
Immunogen
- Anti-GFAP Antibody was produced in mice by repeated immunizations with a synthetic peptide corresponding to amino acids 411-422 (KTVEMRDGEVIK) of human GFAP.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Immunohistochemistry_Dilution: User Optimized
IF_Microscopy_Dilution: User Optimized
Western_Blot_Dilution: 1:1000
-
Comment
-
Anti-GFAP Antibody is tested for use in Western blot, Immunohistochemistry, and Immunocytochemistry. Expect a band approximately ~50 kDa on specific lysates or tissues. Specific conditions for reactivity should be optimized by the end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: 50 % (v/v) Glycerol
Preservative: 0.1 % (w/v) Sodium Azide -
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Expiry Date
- 12 months
-
-
-
: "Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia." in: Scientific reports, Vol. 10, Issue 1, pp. 14271, (2021) (PubMed).
-
: "Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia." in: Scientific reports, Vol. 10, Issue 1, pp. 14271, (2021) (PubMed).
-
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
-
Alternative Name
- GFAP
-
Background
-
Synonyms: Glial fibrillary acidic protein, Intermediate filament protein, Astrocyte, gfapl, DKFZp459C0729, MGC139638, FLJ45472, AI836096, GFAP antibody
Background: The 50 kDa type III intermediate filament protein glial fibrillary acidic protein (GFAP) is a major structural component of astrocytes. GFAP associates with the calcium binding protein annexin II-p2 and S-100. Association with these proteins together with phosphorylation regulates GFAP polymerization. Astroycytes respond to brain injury by proliferatin (astrogliosis), and one of the first events to occur during astrocyte proiliferation is increased GFAP expression. Interestingly, antibodies to GFAP have been detected in individuals with dementia. Anti-GFAP is ideal for investigators involved in Neuroscience Research, including Alexander Disease, Oligodendroglioma, Cytoskleton Remolding Neurofilaments and PIP3/AKT Signaling.
Gene Name: GFAP
-
Gene ID
- 2670
-
UniProt
- P14136
Target
-